BRISTOL Tenn. — The Bristol Tennessee City Council will vote Thursday on the city’s proposed fiscal year 2026 budget and tax rate at a special called meeting, following weeks of debate over ...

Bristol Myers and Celgene are being sued in an antitrust suit, alleging they used fraud, sham litigation, and reverse payments to delay cheaper generics of Pomalyst.

The Bristol, Tennessee City Council is set to have a special-called meeting on Tuesday, which the public is invited to attend and speak with the council.The mee ...

Police are investigating a car crash that shut down multiple roads in Bristol on Monday morning.

Anthony Weiner isn’t the only bad boy attempting a comeback for a City Council seat. Ex-Council members Andy King and Ruben Wills are also seeking seeking redemption at the ballot box.

Thousands of people gathered at Tom Hanafan Park in Council Bluffs Saturday morning, participating in a nationwide series of protests called "No Kings." The effort is in response to President ...

Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.

Pro Stock winner Greg Anderson became just the second NHRA professional racer to record 1,000 elimination round-wins Sunday during the Super Grip Thunder Valley Nationals at Tennessee’s Bristol ...

A protest is underway after a large crowd of people clashed with federal agents in Paramount Saturday morning.

BRISTOL, Tenn. (WJHL) — The Bristol, Tennessee City Council voted Tuesday night to rescind — at least for now — a proposed agreement between the city, school system, and Boyd Sports for the ...

Despite its success in advanced melanoma, Bristol Myers Squibb’s fixed-dose PD-1/LAG-3 combo, Opdualag, failed to move the needle in resected skin cancer. After revealing in February that ...

Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and develop the latter's next-generation cancer immunotherapy, which could take on rival Merck & Co's ...